Activins and
inhibins belong to the
transforming growth factor-beta (
TGF-beta) superfamily of multifunctional
cytokines that bind to transmembrane receptors with
serine/threonine kinase activity. In this study, we characterized the levels of expression of 3
activin/
inhibin subunits (betaA, betaB, alpha), and 2 type I and
type II activin receptors (actRI/Ib, actRII/IIb) in
pancreatic cancer cell lines and in human pancreatic tissues. In addition, we assessed the growth responsiveness to
activin A in these cell lines. All 6 cell lines (ASPC-1, CAPAN-1, COLO-357, MIA-PaCa-2, PANC-1 and T3M4) expressed the
activin/
inhibin betaA subunit, whereas expression levels of the
activin/
inhibin betaB and alpha subunits were undetectable. Furthermore, actRI, actRII and actRIIb were expressed in all cell lines and actRIb
mRNA was evident in ASPC-1, CAPAN-1, COLO-357 and PANC-1 cells. CAPAN-I and COLO-357 cells were growth-stimulated by
activin A in the presence of 10% serum, whereas the other cell lines were resistant to
activin A. In contrast, in serum-free medium
activin A inhibited the growth of CAPAN-1, COLO-357 and MIA-PaCa-2 cells.
Pancreatic cancer samples markedly over-expressed the
activin/
inhibin betaA subunit, whereas the betaB subunit was only moderately increased in comparison to normal pancreatic samples.
Pancreatic cancer tissues also markedly over-expressed actRI, actRIb and actRII. By in situ hybridization,
activin/
inhibin betaA, actRI, actRIb and actRII were strongly expressed in diffuse infiltrative and duct-like
cancer cells. Both the
ligand and its receptors were often co-expressed in these cells. Together, our findings suggest that
activin A may participate in autocrine activation of
pancreatic cancer cells in vivo.